Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
WHO restates opposition to gene-editing live human embryos but endorses other forms of genome modification

WHO restates opposition to gene-editing live human embryos but endorses other forms of genome modification

Megan Molteni | 
[July 12,] a World Health Organization advisory committee called on the world’s largest public health authority to stand by the ...
Viewpoint: Why the FDA’s decision to overrule its evaluatory panel and approve dementia-relief drug Aduhelm was a mistake

Viewpoint: Why the FDA’s decision to overrule its evaluatory panel and approve dementia-relief drug Aduhelm was a mistake

Sam Gandy | 
Like many people, I was shocked when the Food and Drug Administration ignored the advice of its neurological drugs advisory ...
In an unprecedented move hoping to quell criticism, FDA releases documents detailing messy internal debate over Biogen's dementia drug Aduhelm

In an unprecedented move hoping to quell criticism, FDA releases documents detailing messy internal debate over Biogen’s dementia drug Aduhelm

[A] series of documents [were released June 22] by the FDA to explain its decision to use a truncated pathway, ...
‘This was the first time nobody voted for approval of a drug’: Neurologist on FDA panel that negatively evaluated controversial Alzheimer’s drug aducanumab resigns after agency pushes through approval

‘This was the first time nobody voted for approval of a drug’: Neurologist on FDA panel that negatively evaluated controversial Alzheimer’s drug aducanumab resigns after agency pushes through approval

Andrew Joseph | 
Neurologist Joel Perlmutter of Washington University in St. Louis, a member of the FDA’s expert panel for nervous system therapies, ...
History documents hundreds of pandemics over the ages. Understanding how they ended could provide us a roadmap going forward

History documents hundreds of pandemics over the ages. Understanding how they ended could provide us a roadmap going forward

Helen Branswell | 
How did [pandemics of the past] end? The viruses didn’t go away; a descendent of the Spanish flu virus, the ...
'Crisis of confidence': What's causing the panic around AstraZeneca's COVID-19 vaccine?

‘Crisis of confidence’: What’s causing the panic around AstraZeneca’s COVID-19 vaccine?

Matthew Herper | 
AstraZeneca’s Covid-19 vaccine is facing a crisis of confidence, with one European country after another, as if seized by a ...
Vaccine clinical research trials skewed towards White Americans, marginalizing minorities, study finds

Vaccine clinical research trials skewed towards White Americans, marginalizing minorities, study finds

Nicholas St. Fleur | 
An analysis of the demographics of a decade’s worth of vaccine clinical trials has found that Black Americans, Latinos, American ...
COVID evolution: ‘What other variants might be out there?’

COVID evolution: ‘What other variants might be out there?’

Andrew Joseph, Emma Hodcroft | 
Tracking the subtle changes to the virus’ RNA is like global detective work, requiring health officials around the world to ...
unnamed file

Here is COVID good news: It’s jumpstarted biomedical innovation

Anne White | 
As we look back at the past few months, I see three lessons that health care researchers can take from ...
Do asymptomatic carriers spread COVID? Widespread confusion in the early days of the outbreak crippled an effective response

Do asymptomatic carriers spread COVID? Widespread confusion in the early days of the outbreak crippled an effective response

Daniel Oran, Eric Topol | 
Jan. 24 marks the one-year anniversary of a momentous but largely unnoticed event in the history of the Covid-19 pandemic: ...
Coronavirus treatment breakthrough? Eli Lilly’s monoclonal antibody drug shows promise in preventing COVID-19 spread

Coronavirus treatment breakthrough? Eli Lilly’s monoclonal antibody drug shows promise in preventing COVID-19 spread

Matthew Herper | 
In November, the antibody bamlanivimab was authorized for emergency use by the Food and Drug Administration in treating patients with ...
‘Vaccine euphoria’: Why this may be the ‘end of the beginning’ not the ‘beginning of the end’

‘Vaccine euphoria’: Why this may be the ‘end of the beginning’ not the ‘beginning of the end’

Todd Purdum | 
Exuberant headlines about vaccines — Now two! Millions more doses! — have grabbed attention, as have rightfully joyous social media photos ...
'We never got it under control’: COVID modelers say case surge in US and Europe is more than just another wave

‘We never got it under control’: COVID modelers say case surge in US and Europe is more than just another wave

Elizabeth Cooney | 
The consensus among major Covid-19 modelers is that we could see 20,000 to 25,000 deaths in just the next two ...
man getting vaccine web

How should we prioritize a COVID vaccine for communities that have been hit hardest?

Nicholas St. Fleur | 
Frontline health workers, elderly people, and those with chronic conditions that make them especially vulnerable to Covid-19 are likely to ...
cc ap covid us img

Why the US pandemic death rate might be 50 percent more than what is being reported

Andrew Joseph | 
[E]xperts know that the official [COVID-19] death tally is going to be an undercount by some extent. Some people who ...
t z rc eh giek rtrmadp health coronavirus thailand vaccine e

The COVID vaccine race champion appears to be mRNA technology used by Pfizer and Moderna. Here’s a primer

Damian Garde | 
There are about a dozen experimental vaccines in late-stage clinical trials globally, but the ones being tested by Pfizer and Moderna are ...
screen shot at am

Now there are two: Modern’s mRNA COVID-19 vaccine 94.5% successful, joins Pfizer-BioNTech collaboration in targeting pandemic

Helen Branswell, Matthew Herper | 
The Moderna vaccine reduced the risk of Covid-19 infection by 94.5%. There were 95 cases of infection among patients who ...
People's vaccine? Will the wealthiest countries control coronavirus drugs?

People’s vaccine? Will the wealthiest countries control coronavirus drugs?

A. Kayum Ahmed | 
Prime Minister Boris Johnson characterized Britain’s exit from the European Union as “recaptured sovereignty.” These invocations of sovereign power reflect ...
topimage x

What our COVID world might look like over the next year

Andrew Joseph | 
Now — with health authorities saying it may not be until at least the end of 2021 before there’s a ...
ccd e b a fb cf b b c c

Here’s when and how the biotechnology revolution first got lift off

Henry Greely | 
Early in the morning of Tuesday, October 14, 1980, the phone rang at Paul Berg’s house in Stanford, Cal. The ...
hawaiian crow tool use

Corvids are more brainiac than birdbrain: Crows may be able to reflect and ponder their own mind

Sharon Begley | 
Research unveiled on [September 24] in Science finds that crows know what they know and can ponder the content of their ...
unnamed file

Viewpoint: Here’s why excluding pregnant women from COVID vaccine efficacy and safety trials is misguided

Brenna Hughes, Laura Riley | 
To date, more than 140 drug treatments and numerous vaccines are being evaluated to treat and prevent Covid-19 infection. Vaccines ...
mag maternity ss temp slide viao superjumbo

The crisis facing Black women giving birth

Leslie Farrington | 
From the rich and famous to the less well-to-do, Black mothers are often not listened to when they report signs ...
hot topic

US and China buck WHO-backed global effort to expand access to COVID vaccine

Helen Branswell | 
Countries representing about 64% of the world population have signed up to expand global access to Covid-19 vaccines by funding ...
andme and its pharma connections

Drugs tailored to your personal genomics: New partnership between 23andMe and GlaxoSmithKline

Kate Sheridan | 
The California-based [23andMe] is now focused on a partnership with pharma giant GlaxoSmithKline to discover new drugs using data culled ...
f b b bb c df f

Assessing Operation Warp Speed: What’s working, what’s not

Is [Operation Warp Speed] working? Roughly five months after top U.S. health officials coalesced around the idea of a public-private ...
gettyimages custom e d b f eade e d d b f d d s c

For untreatable diseases, should you consider unapproved stem cell therapy?

Natalya Ortolano | 
Regenerative medicine is a controversial field, still in its infancy. There are academic researchers and major biotech companies testing key ...
covid

Life with the pandemic: 4 ways our bodies might respond to new COVID waves

Helen Branswell | 
[Coronavirus researcher Vineet] Menachery laid out four possible scenarios for how humans might interact with SARS-2 over time — in ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists